FDA Phase Out of Animal Test Requirements for Drugs Begins With Biologics - MedCity NewsFDA is moving away from animal testing for experimental drugs, starting with biologics like monoclonal antibodies.
Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions - MedCity NewsPeter Marks' departure from the FDA raises concerns over regulatory support for novel therapies, especially in biologics.
FDA Phase Out of Animal Test Requirements for Drugs Begins With Biologics - MedCity NewsFDA is moving away from animal testing for experimental drugs, starting with biologics like monoclonal antibodies.
Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions - MedCity NewsPeter Marks' departure from the FDA raises concerns over regulatory support for novel therapies, especially in biologics.